D
DND PharmaTech Inc
KOSDAQ:347850
DND PharmaTech Inc
KOSDAQ:347850
Price:
92 300
KRW
15.38%
Market Closed
Market Cap:
₩4T
Balance Sheet
Balance Sheet Decomposition
DND PharmaTech Inc
DND PharmaTech Inc
Balance Sheet Decomposition is not available for
DND PharmaTech Inc
DND PharmaTech Inc
Balance Sheet
DND PharmaTech Inc
DND PharmaTech Inc
Currency: KRW
| Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|
| Assets | ||||
| Cash & Cash Equivalents |
25 504
|
15 642
|
30 014
|
|
| Cash Equivalents |
25 504
|
15 642
|
30 014
|
|
| Total Receivables |
438
|
1 521
|
5 672
|
|
| Accounts Receivables |
125
|
73
|
3 036
|
|
| Other Receivables |
314
|
1 449
|
2 636
|
|
| Other Current Assets |
7 413
|
2 401
|
4 108
|
|
| Total Current Assets |
33 355
|
19 565
|
39 794
|
|
| PP&E Net |
3 024
|
6 422
|
7 729
|
|
| PP&E Gross |
3 024
|
6 422
|
7 729
|
|
| Accumulated Depreciation |
6 751
|
8 883
|
8 183
|
|
| Intangible Assets |
34 246
|
31 615
|
32 476
|
|
| Goodwill |
9 735
|
9 905
|
2 093
|
|
| Note Receivable |
7
|
179
|
4
|
|
| Long-Term Investments |
12 326
|
10 776
|
14 242
|
|
| Other Long-Term Assets |
948
|
741
|
1 162
|
|
| Other Assets |
9 735
|
9 905
|
2 093
|
|
| Total Assets |
93 642
N/A
|
79 204
-15%
|
97 500
+23%
|
|
| Liabilities | ||||
| Accrued Liabilities |
6 455
|
1 781
|
4 014
|
|
| Short-Term Debt |
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
20 808
|
3 014
|
3 602
|
|
| Other Current Liabilities |
27 660
|
2 692
|
3 499
|
|
| Total Current Liabilities |
54 923
|
7 487
|
11 115
|
|
| Long-Term Debt |
6 425
|
5 121
|
6 180
|
|
| Deferred Income Tax |
9 239
|
8 564
|
8 811
|
|
| Minority Interest |
9 079
|
8 568
|
543
|
|
| Other Liabilities |
4 536
|
2 814
|
1 825
|
|
| Total Liabilities |
84 201
N/A
|
32 554
-61%
|
27 388
-16%
|
|
| Equity | ||||
| Common Stock |
4 034
|
4 649
|
5 284
|
|
| Retained Earnings |
293 610
|
289 676
|
309 361
|
|
| Additional Paid In Capital |
263 670
|
292 266
|
331 759
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
6
|
|
| Other Equity |
35 347
|
39 410
|
42 437
|
|
| Total Equity |
9 440
N/A
|
46 650
+394%
|
70 112
+50%
|
|
| Total Liabilities & Equity |
93 642
N/A
|
79 204
-15%
|
97 500
+23%
|
|
| Shares Outstanding | ||||
| Common Shares Outstanding |
42
|
42
|
42
|
|
Switch to:
Switch to:
See Also
Discover More
